188 related articles for article (PubMed ID: 32936291)
1. Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis.
Benzian-Olsson N; Dand N; Chaloner C; Bata-Csorgo Z; Borroni R; Burden AD; Cooper HL; Cornelius V; Cro S; Dasandi T; Griffiths CEM; Kingo K; Koks S; Lachmann H; McAteer H; Meynell F; Mrowietz U; Parslew R; Patel P; Pink AE; Reynolds NJ; Tanew A; Torz K; Trattner H; Wahie S; Warren RB; Wright A; Barker JN; Navarini AA; Smith CH; Capon F;
JAMA Dermatol; 2020 Nov; 156(11):1216-1222. PubMed ID: 32936291
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross-sectional, multicentre study of 263 patients.
Sarıkaya Solak S; Kara Polat A; Kilic S; Oguz Topal I; Saricaoglu H; Karadag AS; Canpolat F; Kartal SP; Deveci BN; Kacar N; Polat Ekinci A; Guner R; Polat M; Dogan G; Guler Ozden M; Bulbul Baskan E; Ozaydin Yavuz G; Adisen E; Gulekon A; Tanribilir ME; Yilmaz O; Akman Karakas A; Ozturk P; Didar Balci D; Gonulal M; Yondem H; Turel Ermertcan A; Sendur N; Topyildiz H; Korkmaz S; Alpsoy E
Clin Exp Dermatol; 2022 Jan; 47(1):63-71. PubMed ID: 34236713
[TBL] [Abstract][Full Text] [Related]
3. Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study.
Brunasso AM; Puntoni M; Aberer W; Delfino C; Fancelli L; Massone C
Br J Dermatol; 2013 Jun; 168(6):1243-51. PubMed ID: 23301847
[TBL] [Abstract][Full Text] [Related]
4. Palmoplantar pustulosis - a cross-sectional analysis in Germany.
Wilsmann-Theis D; Jacobi A; Frambach Y; Philipp S; Weyergraf A; Schill T; Steinz K; Gerdes S; Mössner R
Dermatol Online J; 2017 Apr; 23(4):. PubMed ID: 28541870
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic/Pharmacodynamic Analysis of Guselkumab for Treatment of Palmoplantar Pustulosis: Clinical Implications of Guselkumab Dose, Disease Severity, and Smoking in Japanese Patients.
Iwaki Y; Shibata S; Hu C
J Clin Pharmacol; 2022 Feb; 62(2):182-189. PubMed ID: 34382209
[TBL] [Abstract][Full Text] [Related]
6. Cigarette Smoke Underlies the Pathogenesis of Palmoplantar Pustulosis via an IL-17A-Induced Production of IL-36γ in Tonsillar Epithelial Cells.
Kobayashi K; Kamekura R; Kato J; Kamiya S; Kamiya T; Takano K; Ichimiya S; Uhara H
J Invest Dermatol; 2021 Jun; 141(6):1533-1541.e4. PubMed ID: 33188781
[TBL] [Abstract][Full Text] [Related]
7. Tofacitinib for the Treatment of Nail Lesions and Palmoplantar Pustulosis in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome.
Li C; Li Z; Cao Y; Li L; Li F; Li Y; Xiong D; Wu X; Zhang W; Zeng X
JAMA Dermatol; 2021 Jan; 157(1):74-78. PubMed ID: 32997094
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and Burdens of Disease in Patients from Beijing with Generalized Pustular Psoriasis and Palmoplantar Pustulosis: Multicenter Retrospective Cohort Study Using a Regional Database.
Wang HM; Xu JM; Jin HZ
Am J Clin Dermatol; 2023 Nov; 24(6):991-1002. PubMed ID: 37386353
[TBL] [Abstract][Full Text] [Related]
9. Quality of life and comorbidities in palmoplantar pustulosis - a cross-sectional study on 102 patients.
Trattner H; Blüml S; Steiner I; Plut U; Radakovic S; Tanew A
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1681-1685. PubMed ID: 28252813
[TBL] [Abstract][Full Text] [Related]
10. Pack-year cigarette smoking affects the course of palmoplantar pustulosis.
Putra-Szczepaniak M; Reich A; Jankowska-Konsur A; Czarnecka A; Bagłaj-Oleszczuk M; Hryncewicz-Gwóźdź A
Adv Clin Exp Med; 2021 Feb; 30(2):189-195. PubMed ID: 33636060
[TBL] [Abstract][Full Text] [Related]
11. Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study.
Burden AD; Bissonnette R; Navarini AA; Murakami M; Morita A; Haeufel T; Ye B; Baehner F; Terui T
Dermatol Ther (Heidelb); 2023 Oct; 13(10):2279-2297. PubMed ID: 37731086
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Efficacy and Safety of Apremilast and Methotrexate in Patients with Palmoplantar Psoriasis: A Randomized Controlled Trial.
Kt S; Thakur V; Narang T; Dogra S; Handa S
Am J Clin Dermatol; 2021 May; 22(3):415-423. PubMed ID: 33712987
[TBL] [Abstract][Full Text] [Related]
13. Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort.
Assan F; Husson B; Hegazy S; Seneschal J; Aubin F; Mahé E; Jullien D; Sbidian E; D'Incan M; Conrad C; Brenaut E; Girard C; Richard MA; Bachelez H; Viguier M;
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1578-1583. PubMed ID: 35366356
[TBL] [Abstract][Full Text] [Related]
14. Treatment of pustular psoriasis with anakinra: a statistical analysis plan for stage 1 of an adaptive two-staged randomised placebo-controlled trial.
Cro S; Smith C; Wilson R; Cornelius V
Trials; 2018 Oct; 19(1):534. PubMed ID: 30285894
[TBL] [Abstract][Full Text] [Related]
15. Risks of Comorbidities in Patients With Palmoplantar Pustulosis vs Patients With Psoriasis Vulgaris or Pompholyx in Korea.
Kim DH; Lee JY; Cho SI; Jo SJ
JAMA Dermatol; 2022 Jun; 158(6):650-660. PubMed ID: 35476054
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis.
Andersen YMF; Augustin M; Petersen J; Hagenström K; Mallbris L; Burge R; Egeberg A
Br J Dermatol; 2019 Nov; 181(5):976-982. PubMed ID: 30815849
[TBL] [Abstract][Full Text] [Related]
17. Demographic, clinical, and scintigraphic comparison of patients affected by palmoplantar pustulosis and severe acne: a retrospective study.
Li Y; Li C; Wu N; Li F; Wu Z; Sun X; Li Q; Li L
Clin Rheumatol; 2020 Jun; 39(6):1989-1996. PubMed ID: 31953569
[TBL] [Abstract][Full Text] [Related]
18. Validation and usability of modified palmoplantar psoriasis area and severity index in patients with palmoplantar psoriasis: A prospective longitudinal cohort study.
Nagendran A; Hanumanthu V; Dogra S; Narang T; Venkata Maha Pinnaka L
Indian J Dermatol Venereol Leprol; 2023 May; ():1-8. PubMed ID: 37317722
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study.
Terui T; Okubo Y; Kobayashi S; Sano S; Morita A; Imafuku S; Tada Y; Abe M; Yaguchi M; Uehara N; Handa T; Tanaka M; Zhang W; Paris M; Murakami M
Am J Clin Dermatol; 2023 Sep; 24(5):837-847. PubMed ID: 37233897
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
